FDA Adverse Event Injury Summary report: N

MINI-HEART LOW FLOW NEBULIZER

MDR report key: 525426 · Received April 22, 2004

Report

Report Number
MW1031923
Event Type
Injury
Date Received
April 22, 2004
Date of Event
April 20, 2004
Report Date
April 22, 2004
Manufacturer
WEST MED, INC.
Product Code
CAF
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
MI, US
Reporter Occupation
PHARMACIST

Narratives

Description of Event or Problem · 1

THIS PT WAS ADMITTED IN 2004 TO THE ICU IN STATUS ASTHMATICUS. THEY WERE STARTED ON CONTINUOUS ALBUTEROL NEBULIZATION AT A RATE OF 10 MG/HR. CONTINUED WITH WHEEZING AND SOB. THE NEXT DAY THE ALBUTEROL DOSE WAS INCREASED TO 12 MG/HR. THEY WERE INTUBATED THE FOLLOWING DAY AND CONTINUED ON ALBUTEROL 12 MG/HR. THEY CONTINUED WITH MINIMAL AIR EXCHANGE AND PEAK INSPIRATORY PRESSURE OF 35-42 AND TITAL VOLUME OF 400. THE FOLLOWING DAY THEY REQUIRED PARALYSIS TO HELP MAINTAIN OXYGENATION AND TO TOLERATE VENT SETTINGS. DURING THIS TIME IT WAS NOTED WITHIN THE CONTINUOUS NEBULIZATION DEVICE MINIHEART LOW FLOW NEBULIZER- THE LIQUID WAS FOAMING. SIX DAYS LATER, THE ALBUTEROL WAS CONVERTED TO XOPENEX AND THE FOAMING STOPPED. PT BEGAN DEMONSTRATING IMPROVEMENT IN RESPIRATORY STATUS WITH NO MORE WHEEZING AND MORE AIR EXCHANGE NOTED ON AUSCULTATION. HEART RATE DROPPED FROM 120-130'S TO 100-106. A TRIAL ALBUTEROL FROM THE NEPHRON COMPANY WAS ATTEMPTED. AGAIN NO FURTHER FOAMING OF THE MEDICATION SOLUTION OCCURRED. PT CONTINUED TO IMPROVE TO THE POINT THEY WERE EXTUBATED THE FOLLOWING DAY AT 14:40.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 MINI-HEART LOW FLOW NEBULIZER NEBULIZER CAF WEST MED, INC. 100611 *

Patients

Seq Age Sex Outcome Treatment
1 19 YR Hospitalization 1. LEVAQUIN, 2. CISATRICURIUM, 3. PROPOFOL,| NDC# 24208-347-20.| 4. HEPARIN, 5. FENTANYL, 6. DEXAMETHASONE.| ASTHMATICUS, LOT# 675581, EXP DATE 03/31/05,| ALBUTEROL INHALATION 0.5% 12MG EVERY HOUR. STATUS